Next |
home / stock / akro / akro message board
Subject | By | Source | When |
---|---|---|---|
Profit taking : :) | subslover | investorshub | 01/04/2023 6:51:52 PM |
WOW | TheFinalCD | investorshub | 12/29/2022 10:46:20 PM |
$54 | subslover | investorshub | 12/29/2022 6:30:34 PM |
Hit $50.01 today! | subslover | investorshub | 12/28/2022 7:27:55 PM |
Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY | subslover | investorshub | 12/23/2022 1:12:24 PM |
Nov 16 2022 45.74 0.96 2.14% 44.93 46.495 44.59 537,851 | TheFinalCD | investorshub | 11/24/2022 12:37:10 AM |
G2G. We hit an all-time high today 0f | subslover | investorshub | 11/18/2022 3:38:25 AM |
Anytime MR McDoogi. Check this form 4. the | subslover | investorshub | 10/06/2022 2:37:04 PM |
Thank you so much for ALL the amazing | doogdilinger | investorshub | 10/06/2022 2:31:06 PM |
wow nice day........subs | TheFinalCD | investorshub | 10/05/2022 4:04:01 AM |
We closed @ $38.27. I don't have time | subslover | investorshub | 10/05/2022 12:48:18 AM |
Now they want to do a 175 mil | subslover | investorshub | 09/13/2022 11:55:56 PM |
znewcar1: AKRO 136% v49,3M c29.05 f37,5M H29.78 | znewcar1 | investorshangout | 09/13/2022 8:31:43 PM |
YEAR RANGE $7.52 - $29.78 PREVIOUS CLOSE $12.27 | BigBadWolf | investorshub | 09/13/2022 6:54:30 PM |
znewcar1: PMH31.99 pushing28.3 HOD29.78 S26 | znewcar1 | investorshangout | 09/13/2022 4:40:36 PM |
I like the saying if it's not broken | subslover | investorshub | 09/13/2022 2:15:40 PM |
Ever since June 1st you've been beyond belief | doogdilinger | investorshub | 09/13/2022 2:11:59 PM |
If you get up at 6 am est | subslover | investorshub | 09/13/2022 2:10:25 PM |
Ding ding ding ding ding!!! Another 1 for | doogdilinger | investorshub | 09/13/2022 2:08:02 PM |
In Akero Therapeutics Phase 2b HARMONY Study, Both | subslover | investorshub | 09/13/2022 12:21:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Akero Therapeutics Inc. Company Name:
AKRO Stock Symbol:
NYSE Market:
LOS ANGELES, May 15, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class a...
2024-05-15 09:00:12 ET Liisa Bayko from Evercore ISI issued a price target of $38.00 for AKRO on 2024-05-15 08:06:00. The adjusted price target was set to $38.00. At the time of the announcement, AKRO was trading at $20.3. The overall price target consensus is at $45.00 ...
-- Statistically significant week 96 results from the Phase 2b HARMONY study of EFX in patients with pre-cirrhotic MASH reported during the first quarter of 2024 -- -- Phase 3 SYNCHRONY Histology and SYNCHRONY Real-World studies in patients with pre-cirrhotic MASH (F2-F3) continue to en...